» Articles » PMID: 12401808

Tissue Transglutaminase Mediates Activation of RhoA and MAP Kinase Pathways During Retinoic Acid-induced Neuronal Differentiation of SH-SY5Y Cells

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2002 Oct 29
PMID 12401808
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

All-trans-retinoic acid (RA) plays a crucial role in survival and differentiation of neurons. For elucidating signaling mechanisms involved in RA-induced neuronal differentiation, we have selected SH-SY5Y cells, which are an established in vitro cell model for studying RA signaling. Here we report that RA-induced neuronal differentiation of SH-SY5Y cells is coupled with increased expression/activation of TGase and in vivo transamidation and activation of RhoA. In addition, RA promotes formation of stress fibers and focal adhesion complexes, and activation of ERK1/2, JNK1, and p38alpha/beta/gamma MAP kinases. Using C-3 exoenzyme (RhoA inhibitor) or monodansylcadaverine (TGase inhibitor), we show that transamidated RhoA regulates cytoskeletal rearrangement and activation of ERK1/2 and p38gamma MAP kinases. Further, by using stable SH-SY5Y cell lines (overexpressing wild-type, C277S mutant, and antisense TGase), we demonstrate that transglutaminase activity is required for activation of RhoA, ERK1/2, JNK1, and p38gamma MAP kinases. Activated MAP kinases differentially regulate RA-induced neurite outgrowth and neuronal marker expression. The results of our studies suggest a novel mechanism of RA signaling, which involves activation of TGase and transamidation of RhoA. RA-induced activation of TGase is proposed to induce multiple signaling pathways that regulate neuronal differentiation.

Citing Articles

Distinct conformational states enable transglutaminase 2 to promote cancer cell survival versus cell death.

Aplin C, Zielinski K, Pabit S, Ogunribido D, Katt W, Pollack L Commun Biol. 2024; 7(1):982.

PMID: 39134806 PMC: 11319651. DOI: 10.1038/s42003-024-06672-x.


Transglutaminase 2 in diabetes mellitus: Unraveling its multifaceted role and therapeutic implications for vascular complications.

Ha K Theranostics. 2024; 14(6):2329-2344.

PMID: 38646650 PMC: 11024853. DOI: 10.7150/thno.95742.


HN1 is a novel dedifferentiation factor involved in regulating the cell cycle and microtubules in SH-SY5Y neuroblastoma cells.

Ozar T, Javed A, Ozduman G, Korkmaz K J Cell Biochem. 2024; 126(1):e30569.

PMID: 38629746 PMC: 11730324. DOI: 10.1002/jcb.30569.


Stable knockdown of Drp1 improves retinoic acid-BDNF-induced neuronal differentiation through global transcriptomic changes and results in reduced phosphorylation of ERK1/2 independently of DUSP1 and 6.

Ghani M, Zohar P, Ujlaki G, Toth M, Amsalu H, Poliska S Front Cell Dev Biol. 2024; 12:1342741.

PMID: 38550381 PMC: 10972930. DOI: 10.3389/fcell.2024.1342741.


Cell-Impermeable Inhibitors Confirm That Intracellular Human Transglutaminase 2 Is Responsible for the Transglutaminase-Associated Cancer Phenotype.

Gates E, Calvert N, Cundy N, Brugnoli F, Navals P, Kirby A Int J Mol Sci. 2023; 24(16).

PMID: 37628729 PMC: 10454375. DOI: 10.3390/ijms241612546.